763 related articles for article (PubMed ID: 19960844)
1. An "aggressive" protocol of programmed ventricular stimulation for selecting post-myocardial infarction patients with a low ejection fraction who may not require implantation of an automatic defibrillator.
Belhassen B; Ohayon-Tsioni T; Glick A; Viskin S
Isr Med Assoc J; 2009 Sep; 11(9):520-4, 526, 528. PubMed ID: 19960844
[TBL] [Abstract][Full Text] [Related]
2. Predictive value of ventricular arrhythmia inducibility for subsequent ventricular tachycardia or ventricular fibrillation in Multicenter Automatic Defibrillator Implantation Trial (MADIT) II patients.
Daubert JP; Zareba W; Hall WJ; Schuger C; Corsello A; Leon AR; Andrews ML; McNitt S; Huang DT; Moss AJ;
J Am Coll Cardiol; 2006 Jan; 47(1):98-107. PubMed ID: 16386671
[TBL] [Abstract][Full Text] [Related]
3. Ventricular tachycardia in arrhythmogenic right ventricular dysplasia/cardiomyopathy: clinical presentation, risk stratification and results of long-term follow-up.
Pezawas T; Stix G; Kastner J; Schneider B; Wolzt M; Schmidinger H
Int J Cardiol; 2006 Mar; 107(3):360-8. PubMed ID: 16503259
[TBL] [Abstract][Full Text] [Related]
4. Predictive value of microvolt T-wave alternans in patients with left ventricular dysfunction.
Cantillon DJ; Stein KM; Markowitz SM; Mittal S; Shah BK; Morin DP; Zacks ES; Janik M; Ageno S; Mauer AC; Lerman BB; Iwai S
J Am Coll Cardiol; 2007 Jul; 50(2):166-73. PubMed ID: 17616302
[TBL] [Abstract][Full Text] [Related]
5. Structured care for patients after acute myocardial infarction: sudden cardiac death prevention--data from the Leiden MISSION! AMI study.
Atary JZ; Borleffs CJ; Liem SS; Bax JJ; van der Hoeven BL; Bootsma M; van der Wall EE; van Erven L; Schalij MJ
Europace; 2010 Mar; 12(3):378-84. PubMed ID: 20056593
[TBL] [Abstract][Full Text] [Related]
6. Outcomes of early risk stratification and targeted implantable cardioverter-defibrillator implantation after ST-elevation myocardial infarction treated with primary percutaneous coronary intervention.
Zaman S; Sivagangabalan G; Narayan A; Thiagalingam A; Ross DL; Kovoor P
Circulation; 2009 Jul; 120(3):194-200. PubMed ID: 19581496
[TBL] [Abstract][Full Text] [Related]
7. Prophylactic implantable defibrillator in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia and no prior ventricular fibrillation or sustained ventricular tachycardia.
Corrado D; Calkins H; Link MS; Leoni L; Favale S; Bevilacqua M; Basso C; Ward D; Boriani G; Ricci R; Piccini JP; Dalal D; Santini M; Buja G; Iliceto S; Estes NA; Wichter T; McKenna WJ; Thiene G; Marcus FI
Circulation; 2010 Sep; 122(12):1144-52. PubMed ID: 20823389
[TBL] [Abstract][Full Text] [Related]
8. [Positive microvolt T-wave alternans as a marker of ventricular arrhythmia trigering during cardioverter-defibrillator implantation].
Wierzbowski R; Michałkiewicz D; Cholewa M; Jacewicz K; Gniłka A; Adamus J
Pol Merkur Lekarski; 2006 Oct; 21(124):310-3. PubMed ID: 17205766
[TBL] [Abstract][Full Text] [Related]
9. Sustained polymorphic arrhythmias induced by programmed ventricular stimulation have prognostic value in patients receiving defibrillators.
Greenberg SL; Mauricio Sánchez J; Cooper JA; Cain ME; Chen J; Gleva MJ; Lindsay BD; Smith TW; Faddis MN
Pacing Clin Electrophysiol; 2007 Sep; 30(9):1067-75. PubMed ID: 17725748
[TBL] [Abstract][Full Text] [Related]
10. Long-term outcome of patients who received implantable cardioverter defibrillators for stable ventricular tachycardia.
Glikson M; Lipchenca I; Viskin S; Ballman KV; Trusty JM; Gurevitz OT; Luria DM; Eldar M; Hammill SC; Friedman PA
J Cardiovasc Electrophysiol; 2004 Jun; 15(6):658-64. PubMed ID: 15175060
[TBL] [Abstract][Full Text] [Related]
11. Role of nonsustained ventricular tachycardia and programmed ventricular stimulation for risk stratification in patients with idiopathic dilated cardiomyopathy.
Becker R; Haass M; Ick D; Krueger C; Bauer A; Senges-Becker JC; Voss F; Hilbel T; Niroomand F; Katus HA; Schoels W
Basic Res Cardiol; 2003 Jul; 98(4):259-66. PubMed ID: 12835955
[TBL] [Abstract][Full Text] [Related]
12. Prospective clinical evaluation and follow-up of a cohort of consecutive VT/VF patients, using a staged-care protocol, including coronary arteriography, programmed electrical stimulation and cardiac surgery.
Naccarella F; Rolli A; Carboni A; Finardi A; Aurier E; Favaro L; Contini S; Gherli T; Caponi D; Maranga SS; Lepera G; Bartoletti A
G Ital Cardiol; 1999 Oct; 29(10):1142-56. PubMed ID: 10546124
[TBL] [Abstract][Full Text] [Related]
13. Predictive value of programmed ventricular stimulation in patients with ischaemic cardiomyopathy: implications for the selection of candidates for an implantable defibrillator.
De Ferrari GM; Rordorf R; Frattini F; Petracci B; De Filippo P; Landolina M
Europace; 2007 Dec; 9(12):1151-7. PubMed ID: 17947251
[TBL] [Abstract][Full Text] [Related]
14. The role of implantable cardioverter defibrillator for primary vs secondary prevention of sudden death in patients with idiopathic dilated cardiomyopathy.
Zecchin M; Di Lenarda A; Proclemer A; Faganello G; Facchin D; Petz E; Sinagra G
Europace; 2004 Sep; 6(5):400-6. PubMed ID: 15294264
[TBL] [Abstract][Full Text] [Related]
15. Usefulness of programmed ventricular stimulation in predicting future arrhythmic events in patients with cardiac sarcoidosis.
Aizer A; Stern EH; Gomes JA; Teirstein AS; Eckart RE; Mehta D
Am J Cardiol; 2005 Jul; 96(2):276-82. PubMed ID: 16018857
[TBL] [Abstract][Full Text] [Related]
16. Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction.
Hohnloser SH; Kuck KH; Dorian P; Roberts RS; Hampton JR; Hatala R; Fain E; Gent M; Connolly SJ;
N Engl J Med; 2004 Dec; 351(24):2481-8. PubMed ID: 15590950
[TBL] [Abstract][Full Text] [Related]
17. Age dependent efficacy of implantable cardioverter-defibrillator treatment: observations in 450 patients over an 11 year period.
Trappe HJ; Pfitzner P; Achtelik M; Fieguth HG
Heart; 1997 Oct; 78(4):364-70. PubMed ID: 9404252
[TBL] [Abstract][Full Text] [Related]
18. Implantable cardioverter-defibrillators in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy.
Roguin A; Bomma CS; Nasir K; Tandri H; Tichnell C; James C; Rutberg J; Crosson J; Spevak PJ; Berger RD; Halperin HR; Calkins H
J Am Coll Cardiol; 2004 May; 43(10):1843-52. PubMed ID: 15145110
[TBL] [Abstract][Full Text] [Related]
19. [The implantable cardioverter-defibrillator and hypertrophic cardiomyopathy. Experience at three centers].
Marín F; Gimeno JR; Payá E; García-Alberola A; Pérez-Alvarez L; Fernández X; de la Morena G; Sogorb F; Castro-Beiras A; Valdés M; Martínez JG; Monserrat L
Rev Esp Cardiol; 2006 Jun; 59(6):537-44. PubMed ID: 16790196
[TBL] [Abstract][Full Text] [Related]
20. Prognostic role of post-infarction C-reactive protein in patients undergoing implantation of cardioverter-defibrillators: design of the C-reactive protein Assessment after Myocardial Infarction to GUide Implantation of DEfibrillator (CAMI GUIDE) study.
Bellocci F; Biasucci LM; Gensini GF; Padeletti L; Raviele A; Santini M; Giubilato G; Landolina M; Biondi-Zoccai G; Raciti G; Sassara M; Castro A; Kheir A; Crea F
J Cardiovasc Med (Hagerstown); 2007 Apr; 8(4):293-9. PubMed ID: 17413310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]